UroGen Pharma Ltd. (URGN)
36.83
-0.15
(-0.41%)
USD |
NASDAQ |
Oct 09, 16:00
36.83
0.00 (0.00%)
After-Hours: 20:00
UroGen Pharma EPS Diluted (Quarterly) : -0.2848 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2848 |
| March 31, 2026 | -0.4698 |
| December 31, 2025 | -0.5453 |
| September 30, 2025 | -0.6939 |
| June 30, 2025 | -1.046 |
| March 31, 2025 | -0.9245 |
| December 31, 2024 | -0.7976 |
| September 30, 2024 | -0.5492 |
| June 30, 2024 | -0.9072 |
| March 31, 2024 | -0.9672 |
| December 31, 2023 | -0.7196 |
| September 30, 2023 | -0.6774 |
| June 30, 2023 | -1.029 |
| March 31, 2023 | -1.298 |
| December 31, 2022 | -1.224 |
| September 30, 2022 | -1.133 |
| June 30, 2022 | -1.176 |
| March 31, 2022 | -1.254 |
| December 31, 2021 | -1.268 |
| Date | Value |
|---|---|
| September 30, 2021 | -1.350 |
| June 30, 2021 | -1.174 |
| March 31, 2021 | -1.166 |
| December 31, 2020 | -1.377 |
| September 30, 2020 | -1.306 |
| June 30, 2020 | -1.441 |
| March 31, 2020 | -1.786 |
| December 31, 2019 | -1.857 |
| September 30, 2019 | -1.064 |
| June 30, 2019 | -1.079 |
| March 31, 2019 | -1.109 |
| December 31, 2018 | -1.463 |
| September 30, 2018 | -1.276 |
| June 30, 2018 | -1.142 |
| March 31, 2018 | -0.8765 |
| December 31, 2017 | -0.74 |
| September 30, 2017 | -0.02 |
| June 30, 2017 | -0.70 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xencor, Inc. | -0.2864 |
| MeiraGTx Holdings Plc | 1.713 |
| Insmed, Inc. | -0.0609 |
| Ironwood Pharmaceuticals, Inc. | 0.3068 |
| Viking Therapeutics, Inc. | -1.101 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.35M |
| Revenue (Quarterly) | 72.46M |
| Total Expenses (Quarterly) | 86.81M |
| Enterprise Value | 1.887B |
| Gross Profit Margin (Quarterly) | 90.93% |
| Profit Margin (Quarterly) | -19.81% |
| Earnings Yield | -5.41% |
| Normalized Earnings Yield | -5.414 |